These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type. Nosrati A; Monabati A; Sadeghipour A; Radmanesh F; Safaei A; Movahedinia S Ann Hematol; 2019 Jan; 98(1):169-173. PubMed ID: 30306208 [TBL] [Abstract][Full Text] [Related]
5. Clinical Significance of Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907 [No Abstract] [Full Text] [Related]
6. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma. Landsburg DJ; Petrich AM; Abramson JS; Sohani AR; Press O; Cassaday R; Chavez JC; Song K; Zelenetz AD; Gandhi M; Shah N; Fenske TS; Jaso J; Medeiros LJ; Yang DT; Nabhan C Cancer; 2016 Feb; 122(4):559-64. PubMed ID: 26565895 [TBL] [Abstract][Full Text] [Related]
7. [The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data]. Misyurina AE; Kravchenko SK; Kovrigina AM; Magomedova AU; Plastinina LV; Obukhova TN; Misyurin AV; Misyurin VA; Grebenuk LA; Babaeva FE; Baryakh EA; Vorobiev AI Ter Arkh; 2019 Jul; 91(7):52-62. PubMed ID: 32598736 [TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma. Ye Q; Xu-Monette ZY; Tzankov A; Deng L; Wang X; Manyam GC; Visco C; Montes-Moreno S; Zhang L; Dybkær K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Parsons BM; Møller MB; Piris MA; Winter JN; Medeiros LJ; Hu S; Young KH Oncotarget; 2016 Jan; 7(3):2401-16. PubMed ID: 26573234 [TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma. Huang S; Nong L; Wang W; Liang L; Zheng Y; Liu J; Li D; Li X; Zhang B; Li T Diagn Pathol; 2019 Jul; 14(1):81. PubMed ID: 31315646 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of 'double-hit' and 'double-expression' lymphomas. Ma Z; Niu J; Cao Y; Pang X; Cui W; Zhang W; Li X J Clin Pathol; 2020 Mar; 73(3):126-138. PubMed ID: 31615842 [TBL] [Abstract][Full Text] [Related]
11. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis. Li S; Weiss VL; Wang XJ; Desai PA; Hu S; Yin CC; Tang G; Reddy NM; Medeiros LJ; Lin P Am J Surg Pathol; 2016 Feb; 40(2):253-61. PubMed ID: 26448193 [TBL] [Abstract][Full Text] [Related]
12. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review. Bischin AM; Dorer R; Aboulafia DM Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851 [TBL] [Abstract][Full Text] [Related]
13. Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma. Xu T; Jia Q; Wang Y; Liu Y; Han D; Li P; Ma J; Fan L; Yan Q; Guo S; Li M; Wang Z Diagn Pathol; 2019 May; 14(1):45. PubMed ID: 31109360 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab. Akyurek N; Uner A; Benekli M; Barista I Cancer; 2012 Sep; 118(17):4173-83. PubMed ID: 22213394 [TBL] [Abstract][Full Text] [Related]
15. High-grade B-Cell lymphoma with Rogers TS; Gardner JA; Devitt KA Autops Case Rep; 2019; 9(3):e2019090. PubMed ID: 31440479 [TBL] [Abstract][Full Text] [Related]
16. Generation and characteristics of a novel "double-hit" high grade B-cell lymphoma cell line DH-My6 with Kikuchi H; Higuchi T; Hashida Y; Taniguchi A; Kamioka M; Taguchi T; Yokoyama A; Murakami I; Fujieda M; Daibata M Oncotarget; 2018 Sep; 9(71):33482-33499. PubMed ID: 30323893 [TBL] [Abstract][Full Text] [Related]
17. MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis. Li S; Desai P; Lin P; Yin CC; Tang G; Wang XJ; Konoplev SN; Khoury JD; Bueso-Ramos CE; Medeiros LJ Histopathology; 2016 Jun; 68(7):1090-8. PubMed ID: 26426741 [TBL] [Abstract][Full Text] [Related]
18. Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci. Adams T; Fuchs D; Shadoan PK; Johnstone L; Lau BM; McGhan L; Anwer F; Al-Kateb H Cancer Genet; 2018 Apr; 222-223():25-31. PubMed ID: 29666005 [TBL] [Abstract][Full Text] [Related]
19. Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma. Ryan RJ; Drier Y; Whitton H; Cotton MJ; Kaur J; Issner R; Gillespie S; Epstein CB; Nardi V; Sohani AR; Hochberg EP; Bernstein BE Cancer Discov; 2015 Oct; 5(10):1058-71. PubMed ID: 26229090 [TBL] [Abstract][Full Text] [Related]
20. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas. Pillai RK; Sathanoori M; Van Oss SB; Swerdlow SH Am J Surg Pathol; 2013 Mar; 37(3):323-32. PubMed ID: 23348205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]